Severe recurrent nocturnal hypoglycemia during chemotherapy with 6-mercaptopurine in a child with acute lymphoblastic leukemia
Various endocrine dysfunctions occur during chemotherapy, including hypoglycemia. However, reports of hypoglycemia associated with 6-mercaptopurine (6-MP) are rare. Herein, we report an 8-year-old boy with severe symptomatic hypoglycemia likely due to 6-MP during chemotherapy. He had been diagnosed...
Saved in:
Main Authors: | Eun Mi Cho (Author), Jung Eun Moon (Author), Soo Jung Lee (Author), Cheol Woo Ko (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Pediatric Endocrinology,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Screening of Novel Pharmacogenetic Candidates for Mercaptopurine-Induced Toxicity in Patients With Acute Lymphoblastic Leukemia
by: Minyuan Cao, et al.
Published: (2020) -
Effect of ITPA Polymorphism on Adverse Drug Reactions of 6-Mercaptopurine in Pediatric Patients with Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis
by: Yeonhong Lee, et al.
Published: (2022) -
Star Allele-Based Haplotyping versus Gene-Wise Variant Burden Scoring for Predicting 6-Mercaptopurine Intolerance in Pediatric Acute Lymphoblastic Leukemia Patients
by: Yoomi Park, et al.
Published: (2019) -
The Effect of <i>NUDT15</i>, <i>TPMT</i>, <i>APEX1</i>, and <i>ITPA</i> Genetic Variations on Mercaptopurine Treatment of Pediatric Acute Lymphoblastic Leukemia
by: Jae Min Lee, et al.
Published: (2021) -
ITPA, TPMT, and NUDT15 Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic Leukemia
by: Borhan Moradveisi, et al.
Published: (2019)